Medicine

HIV avoidance through PrEP in cisgender women

.STUDY FEATURE.06 August 2024.

A big randomized measured trial along with cisgender females highlights the obstacles of fidelity to a regular dental preexposure treatment routine as well as shows that twice-yearly treatment of lenacapavir can sustain helpful HIV protection degrees over 6 months.